What’s the future of COVID boosters? FDA vaccine panel moves toward simplifying shots.
Booster scheduling FDA asked the committee to consider whether boosters should be given annually to healthy, young people, and twice a year to older or immune-compromised individuals. Data suggests that people over 75 are particularly vulnerable to severe COVID-19 infections, though the risk starts to rise around the age of 60, though the committee did not make a final recommendation. Also, the risk isn’t consistent across all people with immunocompromising conditions. The FDA’s Peter Marks noted that someone with diabetes may be mildly at risk, while someone undergoing treatment for blood cancer that destroys certain immune cells would have a much higher risk of severe disease.
Table of Contents
